Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paediatric antibiotic allergy de-labelling trial
ACTRN12618000788279Phase 4Recruiting
- Sponsor
- Perth Children's Hospital
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of amoxicillin in drug allergy (2 arms), sponsored by Perth Children's Hospital. Primary endpoints: Choices of antibiotics available after de-labelling, Number of GP visits and 1 more. Started Apr 2018; status: recruiting.
02
Drugs
amoxicillin
03
Conditions
drug allergy
Beyond the preview
Go deeper on ACTRN12618000788279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618000788279.